Abstract
The effect of genetic variants underlying atherosclerosis is thought to be mediated through intermediate phenotypes such as serum cholesterol levels. Localization of quantitative trait loci influencing levels of serum lipids and (apo)lipoproteins may aid in the search for determinants of susceptibility to atherosclerotic diseases. Since apolipoprotein A-I is the primary protein constituent of high-density lipoprotein, it is considered to be critical for the antiatherogenic effect of high-density lipoproteins. We describe here an effort to map loci influencing apolipoprotein A-I levels. Measurements of apolipoprotein A-I levels and genome scans with more than 1000 microsatellite markers were successfully performed in both members of 501 pairs of fraternal twins from Sweden. Variance component linkage analysis was undertaken to map quantitative trait loci. In the total study sample, two loci showed comparable suggestive evidence of linkage, 6p21–12 (LOD=2.4) and 12q23 (LOD=2.4). Sex-limited analyses revealed significant female-specific linkage at marker D15S156 on 15q11–13 (LOD=4.1). The loci on 12q and 15q in the present study confirm previously reported loci for apolipoprotein A-I, while the peak on chromosome 6p lends further support to a locus influencing several phenotypes related to atherosclerosis. Intriguingly, the presence of genes belonging to the phospholipase A2 superfamily under three out of four observed linkage peaks would lend some support to the view that this group of genes might collectively represent candidates as apolipoprotein A-I level regulators.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Thom T, Haase N, Rosamond W et al: Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85–e151.
Hegele RA : Gene–environment interactions in atherosclerosis. Mol Cell Biochem 1992; 113: 177–186.
Kannel WB : The Framingham Study: ITS 50-year legacy and future promise. J Atheroscler Thromb 2000; 6: 60–66.
Barter P, Kastelein J, Nunn A, Hobbs R : High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 2003; 168: 195–211.
Goldbourt U, Yaari S, Medalie JH : Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997; 17: 107–113.
Segrest JP, Harvey SC, Zannis V : Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications. Trends Cardiovasc Med 2000; 10: 246–252.
Barter PJ, Rye KA : The rationale for using apoA-I as a clinical marker of cardiovascular risk. J Intern Med 2006; 259: 447–454.
Beekman M, Heijmans BT, Martin NG et al: Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res 2002; 5: 87–97.
Lichtenstein P, De Faire U, Floderus B, Svartengren M, Svedberg P, Pedersen NL : The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J Intern Med 2002; 252: 184–205.
Lichtenstein P, Sullivan PF, Cnattingius S et al: The Swedish Twin Registry in the third millennium: an update. Twin Res Hum Genet 2006; 9: 875–882.
Bosse Y, Chagnon YC, Despres JP et al: Compendium of genome-wide scans of lipid-related phenotypes: adding a new genome-wide search of apolipoprotein levels. J Lipid Res 2004; 45: 2174–2184.
Falchi M, Andrew T, Snieder H, Swaminathan R, Surdulescu GL, Spector TD : Identification of QTLs for serum lipid levels in a female sib-pair cohort: a novel application to improve the power of two-locus linkage analysis. Hum Mol Genet 2005; 14: 2971–2979.
Heijmans BT, Beekman M, Putter H et al: Meta-analysis of four new genome scans for lipid parameters and analysis of positional candidates in positive linkage regions. Eur J Hum Genet 2005; 13: 1143–1153.
Klos KL, Kardia SL, Ferrell RE, Turner ST, Boerwinkle E, Sing CF : Genome-wide linkage analysis reveals evidence of multiple regions that influence variation in plasma lipid and apolipoprotein levels associated with risk of coronary heart disease. Arterioscler Thromb Vasc Biol 2001; 21: 971–978.
Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Ronnemaa T : Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA 2002; 287: 598–605.
Mikhailidis DP, Wierzbicki AS : HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin. Curr Med Res Opin 2000; 16: 139–146.
Duffy DL : An integrated genetic map for linkage analysis. Behav Genet 2006; 36: 4–6.
Abecasis GR, Cherny SS, Cookson WO, Cardon LR : Merlin – rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97–101.
Hiekkalinna T, Terwilliger JD, Sammalisto S, Peltonen L, Perola M : AUTOGSCAN: powerful tools for automated genome-wide linkage and linkage disequilibrium analysis. Twin Res Hum Genet 2005; 8: 16–21.
Allison DB, Neale MC, Zannolli R, Schork NJ, Amos CI, Blangero J : Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. Am J Hum Genet 1999; 65: 531–544.
Blangero J, Williams JT, Almasy L : Genetic dissection of complex traits; in Rao DC, Province MA (eds): Genetic Dissection of Complex Traits. New York: Academic Press, 2001, pp 161–163.
Lander E, Kruglyak L : Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241–247.
Medland SE : Parameterization of sex-limited autosomal linkage analysis for Mx. Twin Res Hum Genet 2005; 8: 569–573.
Almasy L, Dyer TD, Blangero J : Bivariate quantitative trait linkage analysis: pleiotropy versus co-incident linkages. Genet Epidemiol 1997; 14: 953–958.
Evans DM, Cardon LR : Guidelines for genotyping in genomewide linkage studies: single-nucleotide-polymorphism maps versus microsatellite maps. Am J Hum Genet 2004; 75: 687–692.
Hargrove GM, Junco A, Wong NC : Hormonal regulation of apolipoprotein AI. J Mol Endocrinol 1999; 22: 103–111.
Robinson WP, Lalande M : Sex-specific meiotic recombination in the Prader-Willi/Angelman syndrome imprinted region. Hum Mol Genet 1995; 4: 801–806.
Lercher MJ, Hurst LD : Imprinted chromosomal regions of the human genome have unusually high recombination rates. Genetics 2003; 165: 1629–1632.
Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE : Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 1993; 328: 1150–1156.
Iliadou A, Lichtenstein P, de Faire U, Pedersen NL : Variation in genetic and environmental influences in serum lipid and apolipoprotein levels across the lifespan in Swedish male and female twins. Am J Med Genet 2001; 102: 48–58.
Canizales-Quinteros S, Aguilar-Salinas CA, Reyes-Rodriguez E et al: Locus on chromosome 6p linked to elevated HDL cholesterol serum levels and to protection against premature atherosclerosis in a kindred with familial hypercholesterolemia. Circ Res 2003; 92: 569–576.
Wang X, Paigen B : Genetics of variation in HDL cholesterol in humans and mice. Circ Res 2005; 96: 27–42.
Harrap SB, Wong ZY, Scurrah KJ, Lamantia A : Genome-wide linkage analysis of population variation in high-density lipoprotein cholesterol. Hum Genet 2006; 119: 541–546.
PROCARDIS: A trio family study showing association of the lymphotoxin-alpha N26 (804A) allele with coronary artery disease. Eur J Hum Genet 2004; 12: 770–774.
Packard CJ, O'Reilly DS, Caslake MJ et al: Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 2000; 343: 1148–1155.
Visscher PM, Thompson R, Haley CS : Confidence intervals in QTL mapping by bootstrapping. Genetics 1996; 143: 1013–1020.
Wang X, Paigen B : Quantitative trait loci and candidate genes regulating HDL cholesterol: a murine chromosome map. Arterioscler Thromb Vasc Biol 2002; 22: 1390–1401.
Almasy L, Hixson JE, Rainwater DL et al: Human pedigree-based quantitative-trait-locus mapping: localization of two genes influencing HDL-cholesterol metabolism. Am J Hum Genet 1999; 64: 1686–1693.
Feitosa ME, Rice T, Borecki IB et al: Pleiotropic QTL on chromosome 12q23–q24 influences triglyceride and high-density lipoprotein cholesterol levels: the HERITAGE family study. Hum Biol 2006; 78: 317–327.
Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M : Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387: 414–417.
Wilson SG, Adam G, Langdown M et al: Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort. Eur J Hum Genet 2006; 14: 340–348.
Francke S, Manraj M, Lacquemant C et al: A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. Hum Mol Genet 2001; 10: 2751–2765.
Sykes B, Irven C : Surnames and the Y chromosome. Am J Hum Genet 2000; 66: 1417–1419.
Acknowledgements
This study is supported by the GenomeEUtwin project under the European Commission Programme ‘Quality of Life and Management of the Living Resources’ of 5th Framework Programme (no. QLG2-CT-2002-01254), the Swedish Research Council (no. M-2005-1112) and the Swedish Foundation for Strategic Research. The authors have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Magnusson, P., Boman, M., de Faire, U. et al. Genome-wide search for QTLs for apolipoprotein A-I level in elderly Swedish DZ twins: evidence of female-specific locus on 15q11–13. Eur J Hum Genet 16, 1103–1110 (2008). https://doi.org/10.1038/ejhg.2008.50
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2008.50
